75 related articles for article (PubMed ID: 36115256)
21. Growth hormone--from molecule to mortality.
Sheppard MC
Clin Med (Lond); 2004; 4(5):437-40. PubMed ID: 15536873
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of cabergoline in non-irradiated patients with acromegaly: a multi-centre cohort study.
Urwyler SA; Samperi I; Lithgow K; Mavilakandy A; Matheou M; Bradley K; Pal A; Reddy NL; Ay J; Karavitaki N
Eur J Endocrinol; 2024 Jan; ():. PubMed ID: 38231133
[TBL] [Abstract][Full Text] [Related]
23. DNA Methylation Pattern in Somatotroph Pituitary Neuroendocrine Tumors.
Kober P; Rymuza J; Baluszek S; Maksymowicz M; Nyc A; Mossakowska BJ; Zieliński G; Kunicki J; Bujko M
Neuroendocrinology; 2024; 114(1):51-63. PubMed ID: 37699356
[TBL] [Abstract][Full Text] [Related]
24. A study of acromegaly-associated headache with somatostatin analgesia.
Kaniuka-Jakubowska S; Levy MJ; Pal A; Abeyaratne D; Drake WM; Kyriakakis N; Murray RD; Orme SM; Gohil S; Brooke A; Leese GP; Korbonits M; Wass JA
Endocr Relat Cancer; 2023 Mar; 30(3):. PubMed ID: 36633458
[TBL] [Abstract][Full Text] [Related]
25. Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine.
Gadelha MR; Casagrande A; Strasburger CJ; Bidlingmaier M; Snyder PJ; Guitelman MA; Boguszewski CL; Buchfelder M; Shimon I; Raverot G; Tóth M; Mezősi E; Doknic M; Fan X; Clemmons D; Trainer PJ; Struthers RS; Krasner A; Biller BMK
J Clin Endocrinol Metab; 2024 Jun; ():. PubMed ID: 38828555
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological Analysis of Densely and Sparsely Granulated Somatotroph Tumors of Pituitary.
Wang L; He X; Lu L; Chen L; Peng C; Shao C; Ge R
World Neurosurg; 2024 May; 185():e713-e720. PubMed ID: 38408701
[TBL] [Abstract][Full Text] [Related]
27. Real-world value of cabergoline in the treatment of acromegaly.
Shimon I
Best Pract Res Clin Endocrinol Metab; 2024 Feb; ():101887. PubMed ID: 38443225
[TBL] [Abstract][Full Text] [Related]
28. A Case of Acromegaly With Progressed Diabetic Retinopathy and Sarcopenia Diagnosed Following the Onset of Severe Hypoglycemia.
Kubo H; Sugimoto K; Wada R; Sekikawa N; Inoue M
Cureus; 2024 Apr; 16(4):e58461. PubMed ID: 38765413
[TBL] [Abstract][Full Text] [Related]
29. Growth hormone-secreting pituitary adenoma combined with Graves' disease: retrospective case series and literature review.
Mo C; Tong T; Guo Y; Li Z; Zhong L
Endocr Connect; 2024 Apr; 13(4):. PubMed ID: 38349236
[TBL] [Abstract][Full Text] [Related]
30. The Multibiomarker Acro-TIME Score Predicts fg-SRLs Response: Preliminary Results of a Retrospective Acromegaly Cohort.
Chiloiro S; Moroni R; Giampietro A; Angelini F; Gessi M; Lauretti L; Mattogno PP; Calandrelli R; Tartaglione T; Carlino A; Gaudino S; Olivi A; Rindi G; De Marinis L; Pontecorvi A; Doglietto F; Bianchi A
J Clin Endocrinol Metab; 2024 Apr; 109(5):1341-1350. PubMed ID: 37975821
[TBL] [Abstract][Full Text] [Related]
31. New Treatments for Acromegaly in Development.
Gadelha MR; Gadelha AC; Kasuki L
J Clin Endocrinol Metab; 2024 Mar; 109(4):e1323-e1327. PubMed ID: 37757837
[TBL] [Abstract][Full Text] [Related]
32. Double pituitary neuroendocrine tumors in a patient with normal growth hormone level acromegaly: A case report and review of the literature.
Nakazato I; Oyama K; Ishikawa H; Tabei Y; Inomoto C; Osamura Y; Teramoto A; Matsuno A
Surg Neurol Int; 2023; 14():425. PubMed ID: 38213454
[TBL] [Abstract][Full Text] [Related]
33. A Potent Neutralizing Monoclonal Antibody to Human Growth Hormone Suppresses Insulin-Like Growth Factor-1 in Female Rats.
Hata T; Uematsu Y; Sugita A; Adachi H; Kato S; Hirate M; Ishikura KI; Kaku A; Ohara H; Kojima N; Takahashi T; Kurokawa T
Endocrinology; 2024 Mar; 165(5):. PubMed ID: 38500360
[TBL] [Abstract][Full Text] [Related]
34. Diabetic Ketoacidosis in Acromegaly: A Case Report.
Palakawong P; Arakaki R
Endocr Pract; 2012 Nov; ():1-15. PubMed ID: 23186966
[TBL] [Abstract][Full Text] [Related]
35. Association between β arrestin 2 and filamin A gene variations with medical treatment response in acromegaly patients.
Akdemir AS; Metin Armagan D; Polat Korkmaz O; Ozkaya HM; Kadioglu P; Gazioglu N; Tanriover N; Dirican A; Ozturk M
Minerva Endocrinol (Torino); 2021 Oct; ():. PubMed ID: 34669321
[TBL] [Abstract][Full Text] [Related]
36. Role of IL33 in chronic inflammation and microvascular damage as a reflection of organ damage on a cohort of patients with acromegaly.
Costa D; Pellicano C; Mercuri V; D'Ascanio E; Buglione G; Cicolani G; Basile U; Leodori G; Gargiulo P; Rosato E
J Endocrinol Invest; 2024 Feb; ():. PubMed ID: 38329608
[TBL] [Abstract][Full Text] [Related]
37. Immunological signatures and predictive biomarkers for first-generation somatostatin receptor ligand resistance in Acromegaly.
Luo M; Yu J; Tang R
J Neurooncol; 2024 May; 167(3):415-425. PubMed ID: 38441839
[TBL] [Abstract][Full Text] [Related]
38. Revisiting the usefulness of the short acute octreotide test to predict treatment outcomes in acromegaly.
Marques-Pamies M; Gil J; Valassi E; Hernández M; Biagetti B; Giménez-Palop O; Martínez S; Carrato C; Pons L; Villar-Taibo R; Araujo-Castro M; Blanco C; Simón I; Simó-Servat A; Xifra G; Vázquez F; Pavón I; García-Centeno R; Zavala R; Hanzu FA; Mora M; Aulinas A; Vilarrasa N; Librizzi S; Calatayud M; de Miguel P; Alvarez-Escola C; Picó A; Sampedro M; Salinas I; Fajardo-Montañana C; Cámara R; Bernabéu I; Jordà M; Webb SM; Marazuela M; Puig-Domingo M
Front Endocrinol (Lausanne); 2023; 14():1269787. PubMed ID: 38027102
[TBL] [Abstract][Full Text] [Related]
39. Clinical and prognostic significance of granulation patterns in somatotroph adenomas/tumors of the pituitary: a meta-analysis.
Vuong HG; Dunn IF
Pituitary; 2023 Dec; 26(6):653-659. PubMed ID: 37735314
[TBL] [Abstract][Full Text] [Related]
40. Age, GH/IGF-1 levels, tumor volume, T2 hypointensity, and tumor subtype rather than proliferation and invasion are all reliable predictors of biochemical response to somatostatin analogue therapy in patients with acromegaly: A clinicopathological study.
Durmuş ET; Atmaca A; Kefeli M; Çalışkan S; Mete O; Aslan K; Fidan M; Çolak R; Durmuş B
Growth Horm IGF Res; 2022 Dec; 67():101502. PubMed ID: 36115256
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
